[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Placebo-controlled, Multi-center, Randomized, Phase 2b Study to Evaluate the Efficacy
and Safety of ORMD-0801 in Type 2 Diabetes Mellitus Patients with Inadequate Glycemic Control on Oral
Therapy

What is the purpose of the study?

The purpose of this research study is to test an experimental drug called ORMD-0801, an orally administered formulation of insulin. ORMD-0801 will be referred to as the “study drug” throughout this ICF. An experimental drug is also called an “investigational drug”.

Upstate Institutional Review Board (IRB) Number:

1205579

Study/Protocol ID:

ORA-D-015

Patient Age Group:

Adults

Principal Investigator:

Ruth S Weinstock, MD, PhD

Who can I contact for more information?

Name: Suzan M Bzdick, RN
Phone: 315-464-9006
Email: bzdicks@upstate.edu

Return to Previous Page || Search Again

Top